Agilent has announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the US Food and Drug Administration.
Agilent has announced that it has listed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical devices with the US Food and Drug Administration. Both instruments are manufactured at medical device establishments with the FDA, which is a requirement for manufacturing medical devices.
Gustavo Salem, vice president and general manager, Biological Systems Division, said, “The latest generation of liquid chromatography and mass spec systems that Agilent has registered holds tremendous value for the medical community. We’re being very methodical in bringing this technology to the clinic, while ensuring that the equipment meets the laboratories’ needs.”
For more information please visit ref="http://www.agilent.com">www.agilent.com
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.